OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetes & Metabolism is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Contents - page 1	92
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	72
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	69
Editorial board	62
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	49
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	47
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial	39
Editorial board	37
Contents	37
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	35
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes	35
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	33
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	32
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	31
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	31
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”	30
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	30
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	29
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes	28
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	28
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	27
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	26
Concise review of lipidomics in nonalcoholic fatty liver disease	26
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	26
1-h post-load plasma glucose for detecting early stages of prediabetes	25

Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	25
Sommaire	25
Contents	25